Oral administration of a liquid containing nitrous oxide abolishes vaso-occlusive pain in mice with sickle cell disease
Haematologica
.
2025 Dec 1;110(12):3114-3118.
doi: 10.3324/haematol.2025.287789.
Epub 2025 Jun 5.
Authors
Ana Oddo
1
,
Fuad Abdulla
2
,
Annabelle Herold
1
,
Kathy Tang
1
,
Viacheslav Viatchenko-Karpinski
1
,
Iryna A Khasabova
1
,
Sergey G Khasabov
1
,
Mark Young
3
,
John D Belcher
2
,
Gregory M Vercellotti
2
,
Donald A Simone
4
Affiliations
1
Department of Diagnostic and Biological Sciences, University of Minnesota.
2
Division of Hematology, Oncology and Transplantation, Department of Medicine and Vascular Biology Center, University of Minnesota.
3
Hillhurst Biopharmaceuticals, Inc., San Diego, CA.
4
Department of Diagnostic and Biological Sciences, University of Minnesota. simon003@umn.edu.
PMID:
40468961
PMCID:
PMC12666291
DOI:
10.3324/haematol.2025.287789
No abstract available
Grants and funding
R01 CA241627/CA/NCI NIH HHS/United States
R01 CA263777/CA/NCI NIH HHS/United States
UG3 NS127943/NS/NINDS NIH HHS/United States
UH3 NS127943/NS/NINDS NIH HHS/United States